In vitro fertilization in a patient with ovarian cancer (Stage IC) following conservative surgery and chemotherapy: a case report

A 30-year-old female underwent left salpingo-oophorectomy followed by chemotherapy for Stage IC adenocarcinorna of the ovary. Three years later she had ovarian hyperstimulation and in vitro fertilization (OH-IVF) resulting in a singleton pregnancy. During cesarean section peritoneal washings and biopsies were negative for recurrence. Seven years after the initial diagnosis, the patient is still free of any disease. In conclusion, OH-IVF may be considered in young patients with early ovarian cancer treated with conservative surgery and chemotherapy.

Ovarian cancer; Chemotherapy; IVF

[1]Fauvet R., Poncelet C., Boccara J. et al.: “Fertility after conservative treatment for borderline ovarian tumours: a French multicenter study”. Fertil. Steril., 2005, 83, 284.

[2] Beiner M.E., Gotlieb W.H., Davidson B. et al.: “Infertility treatment after conservative management of borderline ovarian tumours”. Cancer, 2001, 92, 320.

[3] Tangir J., Zelterman D., Ma W., Schwartz P.E.: “Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary”. Obstet. Gynecol., 2003, 101, 251.

[4] Kitagima Y., Endo T., Hayashi T., Ishioka S., Baba T., Honnma H., Saito T.: “A successful IVF-pregnancy in a patient who underwent conservative surgery followed by a regimen of cisplatin, vinblastin and peplomycin to treat an advanced ovarian germ cell tumour: a case report”. Hum. Reprod., 2007, 22, 850.

[5] Steinkampf M.P., Dharia S.P., Hammond K.: “Assisted reproduction in patients with early-stage ovarian malignancies”. Fertil. Steril., 2003, 80, 1510.

[6] Fasouliotis S., Davis O., Schattman G. et al.: “Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumours: a preliminary report”. Fertil. Steril., 2004, 82, 568.

[7] Battaglia F., Plotti F., Zullo M.A., Panici P.B., Plotti G.: “Successful pregnancy after conservative surgery for Stage IC ovarian cancer with serous borderline tumor on contralateral ovary: a case report”. Gynecol. Oncol., 2006, 100, 612.

[8] Whittemore A.S., Harris R., Itnyre J.: “Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies”. Am. J. Epidemiol., 1992, 136, 1184.

[9] Ness R.B., Cramer D.W., Goodman M.T., Kjaer S.K., Mallin K., Mosgaard B.J. et al.: “Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies”. Am. J. Epidemiol., 2002, 155, 217.

[10] Attar E., Berckman S., Topuz S. et al.: “Evolutive peritoneal disease after conservative management and the infertility drugs in a patient with Stage IIIC borderline micropapillary serous carcinoma (MPSC) of the ovary: case report”. Hum. Reprod., 2004, 19, 1472.